Glenmede Trust’s Zoetis ZTS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.25M | Sell |
86,974
-144,900
| -62% | -$13.6M | 0.03% | 426 |
|
|
2026
Q1 | $27.4M | Buy |
231,874
+62,034
| +37% | +$7.67M | 0.13% | 129 |
|
|
2025
Q4 | $21.4M | Buy |
+169,840
| New | +$22.2M | 0.1% | 170 |
|
|
2025
Q1 | $28.6M | Buy |
173,483
+11,398
| +7% | +$1.9M | 0.15% | 133 |
|
|
2024
Q4 | $26.4M | Buy |
162,085
+13,798
| +9% | +$2.47M | 0.13% | 137 |
|
|
2024
Q3 | $29M | Buy |
148,287
+260
| +0.2% | +$47.9K | 0.14% | 143 |
|
|
2024
Q2 | $25.7M | Buy |
148,027
+18,206
| +14% | +$3.03M | 0.13% | 156 |
|
|
2024
Q1 | $22M | Buy |
129,821
+19,466
| +18% | +$3.65M | 0.11% | 191 |
|
|
2023
Q4 | $21.8M | Sell |
110,355
-5,106
| -4% | -$904K | 0.11% | 185 |
|
|
2023
Q3 | $20.1M | Sell |
115,461
-54,264
| -32% | -$9.85M | 0.11% | 189 |
|
|
2023
Q2 | $28.2M | Hold |
169,725
| – | – | 0.16% | 145 |
|
|
2023
Q1 | $28.2M | Sell |
169,725
-2,849
| -2% | -$467K | 0.16% | 145 |
|
|
2022
Q4 | $25.3M | Buy |
172,574
+8,552
| +5% | +$1.27M | 0.15% | 158 |
|
|
2022
Q3 | $24.3M | Buy |
164,022
+6,306
| +4% | +$1.05M | 0.15% | 153 |
|
|
2022
Q2 | $27.1M | Buy |
157,716
+6,960
| +5% | +$1.2M | 0.16% | 149 |
|
|
2022
Q1 | $28.4M | Sell |
150,756
-14,465
| -9% | -$2.86M | 0.14% | 175 |
|
|
2021
Q4 | $40.3M | Buy |
165,221
+1,867
| +1% | +$409K | 0.19% | 122 |
|
|
2021
Q3 | $31.7M | Sell |
163,354
-9,582
| -6% | -$1.93M | 0.16% | 148 |
|
|
2021
Q2 | $32.2M | Sell |
172,936
-1,093
| -0.6% | -$190K | 0.17% | 151 |
|
|
2021
Q1 | $27.4M | Buy |
174,029
+92,517
| +114% | +$14.7M | 0.15% | 169 |
|
|
2020
Q4 | $13.5M | Buy |
81,512
+2,403
| +3% | +$391K | 0.07% | 280 |
|
|
2020
Q3 | $13.1M | Buy |
79,109
+11,795
| +18% | +$1.81M | 0.08% | 269 |
|
|
2020
Q2 | $9.22M | Buy |
67,314
+13,072
| +24% | +$1.71M | 0.06% | 318 |
|
|
2020
Q1 | $7.18M | Hold |
54,242
| – | – | 0.03% | 406 |
|
|
2019
Q4 | $7.18M | Buy |
54,242
+1,581
| +3% | +$196K | 0.03% | 406 |
|
|
2019
Q3 | $6.56M | Sell |
52,661
-12,618
| -19% | -$1.52M | 0.03% | 402 |
|
|
2019
Q2 | $7.41M | Sell |
65,279
-14,951
| -19% | -$1.57M | 0.03% | 409 |
|
|
2019
Q1 | $8.08M | Sell |
80,230
-4,878
| -6% | -$443K | 0.04% | 397 |
|
|
2018
Q4 | $7.28M | Buy |
85,108
+21,753
| +34% | +$1.96M | 0.04% | 398 |
|
|
2018
Q3 | $5.8M | Buy |
63,355
+18,317
| +41% | +$1.62M | 0.02% | 459 |
|
|
2018
Q2 | $3.84M | Buy |
45,038
+22,770
| +102% | +$1.92M | 0.02% | 510 |
|
|
2018
Q1 | $1.6M | Hold |
22,268
| – | – | 0.01% | 693 |
|
|
2017
Q4 | $1.6M | Buy |
22,268
+15,752
| +242% | +$1.08M | 0.01% | 693 |
|
|
2017
Q3 | $414K | Buy |
6,516
+215
| +3% | +$13.5K | ﹤0.01% | 959 |
|
|
2017
Q2 | $335K | Hold |
6,301
| – | – | ﹤0.01% | 1041 |
|
|
2017
Q1 | $335K | Buy |
6,301
+657
| +12% | +$35.5K | ﹤0.01% | 1041 |
|
|
2016
Q4 | $301K | Buy |
5,644
+2,003
| +55% | +$102K | ﹤0.01% | 1092 |
|
|
2016
Q3 | $189K | Buy |
3,641
+691
| +23% | +$35K | ﹤0.01% | 1211 |
|
|
2016
Q2 | $139K | Buy |
2,950
+124
| +4% | +$5.86K | ﹤0.01% | 1281 |
|
|
2016
Q1 | $125K | Buy |
2,826
+75
| +3% | +$3.18K | ﹤0.01% | 1273 |
|
|
2015
Q4 | $131K | Hold |
2,751
| – | – | ﹤0.01% | 1289 |
|
|
2015
Q3 | $112K | Sell |
2,751
-145
| -5% | -$6.72K | ﹤0.01% | 1344 |
|
|
2015
Q2 | $139K | Buy |
2,896
+156
| +6% | +$7.45K | ﹤0.01% | 1332 |
|
|
2015
Q1 | $126K | Sell |
2,740
-5,000
| -65% | -$225K | ﹤0.01% | 1399 |
|
|
2014
Q4 | $332K | Buy |
7,740
+5,689
| +277% | +$231K | ﹤0.01% | 1116 |
|
|
2014
Q3 | $74K | Buy |
2,051
+928
| +83% | +$31.8K | ﹤0.01% | 1583 |
|
|
2014
Q2 | $35K | Sell |
1,123
-1,500
| -57% | -$46K | ﹤0.01% | 1735 |
|
|
2014
Q1 | $75K | Hold |
2,623
| – | – | ﹤0.01% | 1527 |
|
|
2013
Q4 | $85K | Buy |
2,623
+72
| +3% | +$2.3K | ﹤0.01% | 1476 |
|
|
2013
Q3 | $79K | Buy |
2,551
+1,441
| +130% | +$44.1K | ﹤0.01% | 1465 |
|
|
2013
Q2 | $33K | Buy |
+1,110
| New | +$35.9K | ﹤0.01% | 1614 |
|
Other funds holding ZTS
Glenmede Trust's ZTS Position: Q2 2026 in Review
Glenmede Trust reduced its Zoetis (ZTS) stake by 62% in Q2 2026, selling an estimated $13.6M and leaving 86,974 shares worth $6.25M. The position accounts for 0.03% of the portfolio, ranked #426.
Glenmede Trust first reported a position in ZTS in Q2 2013 and has held it in 51 quarters since. The position peaked at $40.3M in Q4 2021. 1,427 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.
- Glenmede Trust held 86,974 shares of Zoetis worth $6.25M as of Q2 2026.
- Glenmede Trust sold 144,900 Zoetis shares in Q2 2026, an estimated $13.6M.
- Zoetis made up 0.03% of Glenmede Trust's portfolio in Q2 2026, its #426 holding.
- Glenmede Trust first reported a position in Zoetis in Q2 2013 and has held it in 51 quarters since.
- Glenmede Trust's Zoetis position peaked at $40.3M in Q4 2021.
- 1,427 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.
Based on Glenmede Trust's 13F filing for Q2 2026, filed 10 Aug 2026.